Enzyme replacement therapy in late-onset type II glycogenosis

European Journal of Neurology

Volumn 16, Issue 7, 2009, Pages

  Ravaglia, S ^a,b   Moglia, A ^b   Costa, A ^b   Repetto, A ^b   Danesino, C ^b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alpha glucosidase; Enzyme replacement therapy; Pompe disease

Indexed keywords

CREATINE KINASE; ENZYME; LACTATE DEHYDROGENASE;

ADULT; AGED; CARBON DIOXIDE TENSION; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; ENDURANCE; ENZYME REPLACEMENT; FORCED EXPIRATORY VOLUME; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LETTER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE MASS; MUSCLE STRENGTH; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; SHORT FORM 36;

AGED; ALPHA-GLUCOSIDASES; CREATINE KINASE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; L-LACTATE DEHYDROGENASE; MIDDLE AGED; WALKING;

EID: 66749126650     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02667.x     Document Type: Letter

References (2)

1. Merk T, Wibmer T, Schumann C, Krüger S. Glycogen storage disease type II (Pompe disease) - influence of enzyme replacement therapy in adults. Eur J Neurol 2009 16 : 274 277.
2. Ravaglia S, Danesino C, Pichiecchio A, et al. Enzyme replacement therapy in severe adult-onset glycogen storage disease type. Adv Ther 2008 25 : 820 829.